What is the patient pathway in pancreatic cancer?

Written by: Dr Shivan Sivakumar
Published: | Updated: 07/08/2024
Edited by: Karolyn Judge

Pancreatic cancer is a serious and often challenging condition to diagnose and treat. Understanding the patient pathway—from initial symptoms to treatment and follow-up - is crucial for patients and their families.

 

This pathway typically involves several stages, including diagnosis, treatment planning and ongoing care. Here to provide a detailed look at this, is leading medical oncologist Dr Shivan Sivakumar.

Man about to begin the patient pathway for pancreatic cancer

What are the initial symptoms and diagnosis?

Pancreatic cancer often presents with vague symptoms, which can make early diagnosis difficult. Common symptoms include:

  • Abdominal pain
  • Jaundice (yellowing of the skin and eyes)
  • Unexplained weight loss
  • Loss of appetite
  • Nausea and vomiting
  • New-onset diabetes

 

When a patient presents with these symptoms, a general practitioner (GP) will conduct a thorough medical history and physical examination. If pancreatic cancer is suspected, the GP will refer the patient to a specialist for further investigation.

 

 

What diagnostic tests are used in the patient pathway?

Several diagnostic tests are used to confirm the presence of pancreatic cancer:

  • Blood tests: These can detect markers such as CA 19-9, which may be elevated in pancreatic cancer.
  • Imaging studies: Ultrasound, CT scans, MRI and PET scans are commonly used to visualise the pancreas and surrounding structures.
  • Endoscopic procedures: An endoscopic ultrasound (EUS) or endoscopic retrograde cholangiopancreatography (ERCP) can provide detailed images and allow for tissue biopsies.
  • Biopsy: A definitive diagnosis is made by examining a tissue sample under a microscope.

 

 

What comes next? Is there a treatment plan?

Once a diagnosis is confirmed, staging is performed to determine the extent of cancer spread. Staging involves imaging studies and possibly surgical exploration. Pancreatic cancer is typically staged from I to IV, with Stage I being localised and Stage IV indicating distant spread.

 

Treatment planning involves a multidisciplinary team (MDT) of specialists, including:

  • Surgeons
  • Oncologists
  • Radiologists
  • Gastroenterologists
  • Pathologists

 

The treatment plan is tailored to the patient's specific stage and overall health.

 

 

What are the treatment options in the pathway?

Treatment options for pancreatic cancer include:

  • Surgery: Potentially curative if the cancer is localised. The most common surgery for tumours in the head of the pancreas, is The Whipple procedure (pancreaticoduodenectomy).
  • Chemotherapy: Used to shrink the tumour before surgery (neoadjuvant therapy), after surgery (adjuvant therapy), or as the primary treatment in advanced stages.
  • Radiotherapy: Often combined with chemotherapy to enhance its effectiveness.
  • Targeted Therapy: Drugs that specifically target cancer cells with less harm to normal cells.
  • Palliative Care: This focuses on relieving symptoms. It improves quality of life for patients with advanced cancer.

 

 

Is there a post-treatment follow-up?

After treatment, regular follow-up is essential to monitor for recurrence and manage any side effects. Follow-up typically includes:

  • Regular physical exams
  • Blood tests, including tumour markers
  • Imaging studies as needed

 

Patients may also receive supportive care, including nutritional support, pain management, and psychological counselling.

 

 

How do I go about living with pancreatic cancer?

Living with pancreatic cancer involves managing ongoing treatment and side effects. Patients are encouraged to:

  • Maintain a healthy diet
  • Stay physically active
  • Seek support. Family, friends and cancer support groups can all help.
  • Communicate openly with their healthcare team about any new symptoms or concerns

 

The patient pathway in pancreatic cancer is complex and requires a coordinated effort from a multidisciplinary team. Early detection and a tailored treatment plan can significantly improve outcomes and quality of life for patients.

 

 

 

Are you about to go ahead with pancreatic cancer treatment? Arrange a consultation with Dr Sivakumar to discuss your options, via his Top Doctors profile.

By Dr Shivan Sivakumar
Medical oncology

Dr Shivan Sivakumar is an esteemed senior medical oncologist at The London Clinic. His expertise includes treating pancreatic cancer, liver cancer, and cholangiocarcinoma (bile duct cancer) with chemotherapy and immunotherapy. Dr Sivakumar is dedicated to finding new solutions for challenging diseases and has led numerous clinical trials and investigative studies.
 
Known for the quality of his patient care and his prompt responsiveness, Dr Sivakumar tailors’ treatment plans to individual needs and offers home-based chemotherapy treatments.
 
Dr Sivakumar holds an honorary consultant position in medical oncology at Oxford University Hospitals NHS Foundation Trust and is a clinical career development fellow in medical oncology at the University of Oxford. He also serves as the pancreatic cancer lead for the Sichuan University (West China Hospital)-Oxford University Gastrointestinal Cancer Centre, an international collaboration aimed at improving cancer treatment.
 
He graduated from Queen Mary University of London with a Bachelor of Medicine, Bachelor of Surgery degree, and became a member of the Royal College of Surgeons. In 2014, he earned a PhD in Biochemistry from the University of Cambridge. He completed post-doctoral studies in immunology and training in early phase clinical trials at the University of Oxford.
 
Currently, Dr Sivakumar is an honorary consultant in Medical Oncology at the University Hospitals Birmingham NHS Foundation Trust. He previously served as a clinical career development fellow and honorary consultant at Oxford University Hospitals NHS Trust, and his clinical training includes experience in Leeds, Wales, and Oxford.
 
As a research-active oncologist, Dr Sivakumar focuses on improving survival rates for patients with pancreatic cancer. His work includes early diagnosis, conducting clinical trials, and identifying new therapeutic targets through studying the biology of the disease.
 
Dr Sivakumar chose Birmingham for its strong clinical expertise in pancreatic cancer, robust academic immunology program, and excellent access to patient samples. He treats patients with pancreatic, liver, and biliary tract cancers (HPB cancers) and oversees an active trials program in these areas. He is part of one of Europe’s largest oncology clinical practices for HPB cancers at Queen Elizabeth Hospital, which sees nearly 500 new patients annually.
 
Dr Sivakumar has secured several million pounds in funding from public, private, and charitable sources. His strong connections with the pharmaceutical industry have led to a significant collaboration with Bristol Myers Squibb in pancreatic cancer research. He serves on several national committees and has received the 2020 NCRI Future of Research Award and the 2023 Royal College of Physicians Linacre Lectureship.
 
Dr Sivakumar continues to conduct research, with his findings published in numerous peer-reviewed journals. He is committed to advancing cancer treatment and improving patient care through his ongoing research and clinical work.

View Profile

Overall assessment of their patients


  • Related procedures
  • Prostate cancer
    Breast cancer
    Bone cancer
    Nervous system malformations
    Brain tumour
    Bone marrow cancers
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Neuro-oncology
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.